Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000480331 | SCV000572171 | pathogenic | not provided | 2024-06-17 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 37171956, 33947782, 37161764, 38192228) |
Undiagnosed Diseases Network, |
RCV000991220 | SCV001142600 | uncertain significance | CHRNA3-related disorder | 2019-05-17 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000991220 | SCV004116618 | likely pathogenic | CHRNA3-related disorder | 2023-01-30 | criteria provided, single submitter | clinical testing | The CHRNA3 c.907_908delCT variant is predicted to result in a frameshift and premature protein termination (p.Leu303Aspfs*115). This variant has been reported in the compound heterozygous or homozygous states in three individuals from two unrelated families with autonomic ganglionopathy (Shibao et al 2021. PubMed ID: 33947782). This variant is reported in 0.029% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/15-78894075-CAG-C). Frameshift variants in CHRNA3 are expected to be pathogenic. This variant is interpreted as likely pathogenic. |